Politico August 5, 2024
By Ben Leonard and Chelsea Cirruzzo

Driving The Day

MDMA GETS A BIPARTISAN BOOST — A bipartisan group in Congress, led by an unlikely front man, Rep. Jack Bergman (R-Mich.), a three-star retired Marine Corps general, is waging a psychedelic drug pressure campaign on the Food and Drug Administration, POLITICO’s Erin Schumaker reports.

Bergman’s ask to the FDA: Consider the science. Then approve Lykos Therapeutics’ application for MDMA — also known as ecstasy — with talk therapy to treat post-traumatic stress disorder.

“Every day that goes by that research isn’t being done, that’s more lives being lost, primarily to suicide,” Bergman, who, with Democrat Lou Correa of California, co-chairs the Psychedelics Advancing Therapies Caucus, told Erin. “A lot of those veterans are on a dark path.”

...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Congress / White House, FDA, Govt Agencies, Mental Health, Pharma, Pharma / Biotech, Provider
988 Mental Health Hotline Failed to Boost Service Offerings
Suicide hotline has not led to increased mental health service access: Study
Private Equity Investors Are Still Laser-Focused on Behavioral Health Care
Private Equity in Behavioral Health: Compliance Champions or Cost-Cutting Villains?
Private equity-backed company acquires New York behavioral provider

Share This Article